Cu-Doped MnO2 Nanoparticles Loaded with Docetaxel Synergistically Enhance Chemodynamic Therapy through Ferroptosis and Cuproptosis
Lekang Liu,
No information about this author
Mingbo Shao,
No information about this author
Linna Guo
No information about this author
et al.
ACS Applied Nano Materials,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 17, 2025
We
have
developed
an
innovative
Cu-doped
and
DTX-loaded
Cu-MnO2@DTX@FA
(MCDF)
nanodrug
designed
to
strategically
alter
tumor
microenvironment
(TME)
by
harnessing
the
synergistic
effects
of
chemodynamic
therapy
(CDT),
chemotherapeutic
agents,
induction
ferroptosis
cuproptosis.
The
MCDF
efficiently
degrades,
releasing
abundant
Mn4+,
Cu2+,
DTX.
conversion
Cu2+
Cu+
facilitated
FDX1
initiates
cuproptosis,
while,
similar
Mn2+,
reacts
with
hydrogen
peroxide
(H2O2)
generate
hydroxyl
radicals
(·OH).
Mn4+
oxidize
glutathione
(GSH),
significantly
depleting
GSH
levels
in
cells
inactivating
GPX4,
which
further
promotes
ferroptosis.
release
intensifies
DTX
effectively
disrupts
cell
division
cycle,
thereby
inhibiting
proliferation
spread
cells.
FA-modified
is
evade
immune
detection
while
selectively
targeting
tissues,
ensuring
precision
treatment
delivery.
This
cutting-edge
material
not
only
provides
a
multifunctional
therapeutic
strategy
but
also
sets
stage
for
next
generation
tumor-targeting
nanomedicines.
Language: Английский
Beyond chemotherapy: Spatiotemporal activation of metal complexes for deep-tissues precision medicine
Yida Pang,
No information about this author
Fang Zhao,
No information about this author
Yuting Wang
No information about this author
et al.
Coordination Chemistry Reviews,
Journal Year:
2025,
Volume and Issue:
535, P. 216664 - 216664
Published: March 30, 2025
Language: Английский
Renal-Clearable Molecular Reporters for Near-Infrared Fluorescence Imaging and Urinalysis of Pulmonary Metastatic Tumor
Ya Zhou,
No information about this author
Jun Chen,
No information about this author
Yang Zhou
No information about this author
et al.
Analytical Chemistry,
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 11, 2025
Despite
approximately
40%
of
all
patients
with
cancer
developing
pulmonary
metastases
in
the
course
their
disease,
it
remains
a
diagnostic
challenge
clinical
practice.
Herein,
we
propose
fluorogenic
probe
(CPRG)
gamma-glutamyl
transferase
(GGT)-triggered
signal
turn-on
for
near-infrared
fluorescence
imaging
(NIRF)
and
urinalysis
orthotopic
metastatic
tumors
living
mice.
CPRG
comprised
four
key
moieties:
GGT-reactive
moiety,
hemicyanine-based
unit,
polyethylene
glycol
linker,
an
active
tumor
targeting
moiety.
Such
tailored
is
intrinsically
nonfluorescent
only
activates
its
NIRF
signals
presence
GGT.
After
intratracheal
administration
into
lungs
tumor-bearing
mice,
can
efficiently
accumulate
sensitively
real-time
imaging.
Relying
on
high
renal
clearance
efficiency
(∼70%
ID),
be
rapidly
excreted
through
kidneys
assessed
by
chemotherapeutic
efficacy
cisplatin.
This
study
not
reports
tracers
but
also
provides
guidelines
development
molecular
probes
companion
diagnosis
cancer.
Language: Английский
Substituent‐Modulated Excited Triplet States and Activities of Ruthenium Complexes for Dual Photodynamic/Sonodynamic Therapy to Cisplatin‐Resistant Non‐Small Cell Lung Cancer
Dan-Dan Xie,
No information about this author
Xuelian Li,
No information about this author
Lizhen Zeng
No information about this author
et al.
ChemBioChem,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Nov. 19, 2024
Six
polypyridyl
Ru(II)
complexes
were
designed
for
single-molecule
photodynamic
and
sonodynamic
therapy
(PDT/SDT)
synergistic
multimodal
anticancer
toward
cisplatin-resistant
NSCLC.
They
demonstrated
lowest
3ES
with
distinct
intraligand
transition
nature,
which
is
beneficial
singlet
oxygen
generation.
Remarkable
quantum
yields
of
both
superoxide
anion
under
either
808
nm
laser
irradiation
or
ultrasonic
treatment
could
induce
apoptosis
ferroptosis
A549R
cells.
Cytotoxicity
experiments
clearly
a
effect
between
PDT
SDT.
The
relationship
the
structures
these
their
cellular
biological
mechanisms
has
been
explored
in
detail.
Using
sensitizer
to
achieve
PDT/SDT
may
provide
valuable
insights
drug-resistant
tumors
that
located
deeply
hypoxic
microenvironment.
Language: Английский
Lysosome‐Targeted Bifunctional Fluorescent Probe and Type I/II Photosensitizer for Viscosity Imaging and Cancer Photodynamic Therapy
Du Liu,
No information about this author
Hongyan An,
No information about this author
Xianglong Li
No information about this author
et al.
Luminescence,
Journal Year:
2024,
Volume and Issue:
39(11)
Published: Nov. 1, 2024
Abnormal
lysosomal
viscosity
is
closely
associated
with
cancer
progression,
underscoring
the
need
for
bifunctional
fluorescent
probes
and
photosensitizers
(PSs)
that
can
both
monitor
facilitate
imaging-guided
therapy
simultaneous
diagnosis
treatment.
Despite
advances
in
lysosome-targeted
PSs
development,
few
have
demonstrated
ability
to
generate
Type
I
II
reactive
oxygen
species
(ROS).
In
this
study,
we
present
BTTPA,
a
probe
photosensitizer,
designed
integrate
via
imaging
treatment
through
photodynamic
(PDT).
Our
findings
reveal
BTTPA
selectively
targets
lysosomes,
enabling
dynamic
monitoring
of
cellular
distinguishing
cells
from
normal
cells.
Upon
light
activation,
efficiently
generates
ROS.
Apoptosis
assays
further
confirm
BTTPA's
effectiveness
inducing
cell
apoptosis,
highlighting
its
potential
as
powerful
tool
therapy.
Language: Английский